United States, Aug. 11 -- BASF announces availability of Bemotrizinol (BEMT), marketed under the BASF trademark Tinosorb(R) S, in the United States following the recent approval of Bemotrizinol as a sunscreen active ingredient by the U.S. Food and Drug Administration (FDA).BASF confirms that it is authorized to market and sell Bemotrizinol (Tinosorb S) in the United States pursuant to a Supplemental License Agreement with DSM Nutritional Products LLC. Under this agreement, BASF has been granted co-exclusive rights to market and sell Bemotrizinol during the FDA's 18-month exclusivity period, including for use in sunscreen products manufactured in the United States and/or imported into the United States.Tinosorb S (Bemotrizinol) is a highly e...